Latest debt-to-equity ratio
Metagenomi Therapeutics Debt-to-equity ratio
Direct answer
Metagenomi Therapeutics's debt-to-equity ratio is 33.51%.
The verified market snapshot reports 33.51%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 3, 2026.
Get free Metagenomi Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 33.51%
Explore related company data
View Metagenomi Therapeutics's market capitalizationView Metagenomi Therapeutics's price-to-book ratioView Metagenomi Therapeutics's return on equityView Metagenomi Therapeutics's 52-week price rangeView Metagenomi Therapeutics's profit marginView all Metagenomi Therapeutics key metricsReturn to Metagenomi Therapeutics profile